Effect of vildagliptin as add-on therapy to a low-dose metformin

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 1, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

615

HTML

4150

Figures (1-3)

603

Tables (1-2)

442

Sum=5810

Mar 15, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Articles

World J Diabetes. Mar 15, 2010; 1(1): 19-26
Published online Mar 15, 2010. doi: 10.4239/wjd.v1.i1.19

Figure 1 Study design.

Open in New Tab Full Size Figure Download Figure

Figure 2 Patient flow diagram. ^aDose after titration at Visit 4 (Week 6).

Figure 3 Mean HbA_1c (%) by treatment and visit. Data are presented as mean ± SEM. vilda: vildagliptin/metformin; met: metformin.

Citation: Filozof C, Schwartz S, Foley JE. Effect of vildagliptin as add-on therapy to a low-dose metformin. World J Diabetes 2010; 1(1): 19-26
URL: https://www.wjgnet.com/1948-9358/full/v1/i1/19.htm
DOI: https://dx.doi.org/10.4239/wjd.v1.i1.19